Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MDT
MDT logo

MDT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
75.850
Open
75.850
VWAP
74.44
Vol
22.24M
Mkt Cap
94.76B
Low
73.670
Amount
1.66B
EV/EBITDA(TTM)
11.43
Total Shares
1.28B
EV
114.66B
EV/OCF(TTM)
15.74
P/S(TTM)
--
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Show More

Events Timeline

(ET)
2026-05-21
07:10:00
Covalon Q2 Revenue Grows 15% Year-over-Year to $8.7M
select
2026-05-20 (ET)
2026-05-20
09:20:00
Medtronic Plans to Acquire SPR Therapeutics for $650 Million
select
2026-04-30 (ET)
2026-04-30
10:00:00
Orchestra BioMed Receives Second Breakthrough Device Designation from FDA
select
2026-04-30
07:20:00
Teleflex Appoints Jason Weidman as New CEO
select
2026-04-26 (ET)
2026-04-26
22:00:00
Sun Pharma to Acquire Organon for $14 Per Share
select
2026-04-26
13:50:00
Medtronic Announces Continued Growth for Cardiac Technologies
select

News

CNBC
9.5
05-31CNBC
Earnings Reports and Tech Conferences This Week
  • Earnings Reports: This week, Palo Alto Networks, CrowdStrike, and Broadcom are set to report earnings, with Palo Alto expected to post $0.80 per share on $2.94 billion in revenue, while CrowdStrike is projected to report $1.07 per share on $1.36 billion, highlighting strong market interest in cybersecurity.
  • AI-Driven Market Rebound: As AI technology becomes more prevalent, both Palo Alto and CrowdStrike have seen their stock prices rebound to all-time highs, and despite facing high valuation pressures, market expectations for their future performance remain optimistic, making management's outlook a key focus for investors.
  • Tech Conference Highlights: Nvidia, Arm, and Microsoft will discuss AI-related topics at tech conferences this week, with Nvidia CEO Jensen Huang scheduled to deliver a keynote on Monday, where he is expected to unveil a new product, potentially personal computers powered by its GPUs, further boosting its market share.
  • Labor Market Data: The JOLTS report will be released this week, with expectations of 120,000 new private sector jobs added in May and an unemployment rate holding steady at 4.3%, reflecting economic resilience, and investors will closely monitor these figures for their potential impact on inflation and monetary policy.
Fool
5.0
05-30Fool
Preparing for Economic Recession: Resilient Stock Picks
  • Consumer Resilience: Coca-Cola and Procter & Gamble, both Dividend Kings, maintain high dividend yields of 2.6% and 2.9% respectively, showcasing their robust business models and market adaptability, which help stabilize cash flow during economic downturns.
  • Healthcare Sector Stability: Johnson & Johnson and Medtronic also demonstrate strong performance in the healthcare sector, offering dividend yields of 2.3% and 3.6%, indicating that the inelastic demand for medical care allows these companies to remain profitable amid economic fluctuations.
  • Valuation Insights: Coca-Cola's price-to-earnings ratio is slightly below its five-year average, suggesting reasonable pricing, while Procter & Gamble's P/E is even lower, indicating potential undervaluation that may attract value investors.
  • Portfolio Strategy: Given the increasing risk of economic recession, investors are advised to consider adding these resilient consumer and healthcare stocks to their portfolios to mitigate potential economic downturn risks.
NASDAQ.COM
6.5
05-30NASDAQ.COM
Resilient Stocks to Consider Amid Recession Fears
  • Resilient Sector Focus: In light of impending economic recessions, investors are advised to concentrate on resilient sectors such as consumer staples and healthcare, which maintain stable cash flows and profitability by selling essential everyday products even during downturns.
  • Coca-Cola and Procter & Gamble: Both companies, recognized as 'Dividend Kings', offer dividend yields of 2.6% and 2.9% respectively, with their price-to-earnings ratios currently below their five-year averages, indicating that their stock prices are reasonably valued and suitable for income-seeking investors.
  • Strong Healthcare Options: Johnson & Johnson and Medtronic also demonstrate resilience in the healthcare sector, with dividend yields of 2.3% and 3.6% respectively; while J&J's P/E is above its five-year average, its diversified operations provide investors with effective risk management.
  • Medtronic's Growth Potential: Medtronic achieved its highest revenue growth rate in ten quarters during Q3 of fiscal 2026, and although the company is undergoing restructuring to enhance innovation, its attractive dividend yield compensates investors for their patience during this transition.
CNBC
9.5
05-29CNBC
Dell Technologies Poised to Dominate Computer Market
  • Dell's Impressive Earnings: Dell Technologies' latest earnings report is described as a 'blowout,' indicating strong market demand that could signify its dominance in the computer space, further fueling enthusiasm around data center trades.
  • Nvidia's Challenges: While tech stocks have performed well, Nvidia has emerged as a notable laggard, with expectations that CEO Jensen Huang's upcoming keynote at Computex in Taiwan could introduce new products and potentially shift this trend.
  • Market Dynamics to Watch: Next week, Merck will review its cancer portfolio, while Palo Alto Networks and Ulta are set to report earnings; Cramer anticipates that these companies may be influenced by AI-driven market changes, particularly in cybersecurity.
  • Employment Data Impact: The Labor Department's jobs report on Friday will shape expectations for interest rate cuts, with Cramer noting that the data needs to be weak enough to justify a rate cut from the Federal Reserve, which could influence investor decisions.
Newsfilter
9.5
05-29Newsfilter
Dell Technologies Earnings Ignite AI Enthusiasm
  • Dell's Blockbuster Earnings: Dell Technologies' recent earnings report is described as a 'blowout,' reigniting enthusiasm for AI and data center stocks, and potentially marking a pivotal moment for its dominance in the computer space.
  • Nvidia's Lagging Performance: Despite the strong performance of tech stocks, Nvidia has emerged as a laggard, with Cramer suggesting that next week's Computex keynote by CEO Jensen Huang could provide crucial updates that may shift this trend.
  • Upcoming Earnings Reports: A series of earnings reports from companies like Palo Alto and Broadcom next week are expected to offer significant insights for investors, particularly regarding the rising AI-driven cybersecurity threats that could impact results.
  • Lululemon's Reset Quarter: Cramer cautions that Lululemon may face a challenging 'reset quarter,' advising investors to be cautious ahead of the earnings report to mitigate potential losses.
NASDAQ.COM
7.5
05-29NASDAQ.COM
Trane Technologies Market Cap Reaches $99.97 Billion
  • Market Cap Comparison: Trane Technologies (TT) boasts a market cap of $99.97 billion compared to Medtronic (MDT) at $97.02 billion, indicating a competitive edge that may attract more attention from large funds.
  • Investor Misconceptions: Many novice investors mistakenly compare stock prices to gauge company value, yet market capitalization provides a more accurate assessment, enabling smarter investment decisions.
  • Market Positioning Impact: A company's market cap not only affects its ranking among peers but also determines which mutual funds and ETFs may invest in the stock, influencing its liquidity and market performance.
  • Stock Price Fluctuations: At Friday's close, TT's stock fell approximately 0.1%, while MDT's dropped about 2.4%, reflecting differing market sentiments and expectations for the two companies.
Wall Street analysts forecast MDT stock price to rise
20 Analyst Rating
Wall Street analysts forecast MDT stock price to rise
11 Buy
9 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
102.00
Averages
111.76
High
120.00
Current: 0.000
sliders
Low
102.00
Averages
111.76
High
120.00
Jefferies
Matthew Taylor
Hold
downgrade
$108 -> $95
AI Analysis
2026-04-23
Reason
Jefferies
Matthew Taylor
Price Target
$108 -> $95
AI Analysis
2026-04-23
downgrade
Hold
Reason
Jefferies analyst Matthew Taylor lowered the firm's price target on Medtronic (MDT) to $95 from $108 and keeps a Hold rating on the shares. The firm updated its FY26 EPS outlook to reflect MiniMed (MMED) IPO timing and one-time expenses for Minimed Flex. Jefferies added that Medtronic's announced one-time $157M charge in Q4 related to the present value of future payments owed to Blackstone for the MiniMed Flex launch added to the EPS guide revision.
UBS
Neutral
downgrade
$104 -> $90
2026-04-22
Reason
UBS
Price Target
$104 -> $90
2026-04-22
downgrade
Neutral
Reason
UBS lowered the firm's price target on Medtronic to $90 from $104 and keeps a Neutral rating on the shares. The firm updated its model to reflect the diabetes separation.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MDT
Unlock Now

Valuation Metrics

The current forward P/E ratio for Medtronic PLC (MDT.N) is 12.45, compared to its 5-year average forward P/E of 16.67. For a more detailed relative valuation and DCF analysis to assess Medtronic PLC's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
16.67
Current PE
12.45
Overvalued PE
18.96
Undervalued PE
14.39

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
14.19
Current EV/EBITDA
11.51
Overvalued EV/EBITDA
15.93
Undervalued EV/EBITDA
12.46

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.62
Current PS
2.56
Overvalued PS
4.27
Undervalued PS
2.97

Financials

AI Analysis
Annual
Quarterly

Whales Holding MDT

C
Citadel Advisors LLC
Holding
MDT
+22.54%
3M Return
S
SG Americas Securities, LLC
Holding
MDT
+20.99%
3M Return
A
Argenta Asset Management SA
Holding
MDT
+20.17%
3M Return
D
Dakota Wealth, LLC
Holding
MDT
+19.34%
3M Return
E
Epoch Investment Partners, Inc.
Holding
MDT
+19.23%
3M Return
C
Crossmark Global Investments, Inc.
Holding
MDT
+17.97%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Medtronic PLC (MDT) stock price today?

The current price of MDT is 73.81 USD — it has decreased -2.33

What is Medtronic PLC (MDT)'s business?

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

What is the price predicton of MDT Stock?

Wall Street analysts forecast MDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MDT is111.76 USD with a low forecast of 102.00 USD and a high forecast of 120.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Medtronic PLC (MDT)'s revenue for the last quarter?

Medtronic PLC revenue for the last quarter amounts to 9.02B USD, increased 8.74

What is Medtronic PLC (MDT)'s earnings per share (EPS) for the last quarter?

Medtronic PLC. EPS for the last quarter amounts to 0.89 USD, decreased -11.88

How many employees does Medtronic PLC (MDT). have?

Medtronic PLC (MDT) has 95000 emplpoyees as of June 01 2026.

What is Medtronic PLC (MDT) market cap?

Today MDT has the market capitalization of 94.76B USD.